Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 157

1.

Genetic contribution of ABCC2 to Dubin-Johnson syndrome and inherited cholestatic disorders.

Corpechot C, Barbu V, Chazouillères O, Broué P, Girard M, Roquelaure B, Chrétien Y, Dong C, Lascols O, Housset C, Jéru I.

Liver Int. 2019 Sep 22. doi: 10.1111/liv.14260. [Epub ahead of print]

PMID:
31544333
2.

Structural analogues of roscovitine rescue the intracellular traffic and the function of ER-retained ABCB4 variants in cell models.

Vauthier V, Ben Saad A, Elie J, Oumata N, Durand-Schneider AM, Bruneau A, Delaunay JL, Housset C, Aït-Slimane T, Meijer L, Falguières T.

Sci Rep. 2019 Apr 30;9(1):6653. doi: 10.1038/s41598-019-43111-y.

3.

Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis.

Lemoinne S, Kemgang A, Ben Belkacem K, Straube M, Jegou S, Corpechot C; Saint-Antoine IBD Network, Chazouillères O, Housset C, Sokol H.

Gut. 2019 Apr 19. pii: gutjnl-2018-317791. doi: 10.1136/gutjnl-2018-317791. [Epub ahead of print]

PMID:
31003979
4.

Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis.

Lemoinne S, Cazzagon N, El Mouhadi S, Trivedi PJ, Dohan A, Kemgang A, Ben Belkacem K, Housset C, Chretien Y, Corpechot C, Hirschfield G, Floreani A, Motta R, Gallix B, Barkun A, Barkun J, Chazouillères O, Arrivé L.

Clin Gastroenterol Hepatol. 2019 Mar 15. pii: S1542-3565(19)30277-0. doi: 10.1016/j.cgh.2019.03.013. [Epub ahead of print]

PMID:
30880273
5.

Editorial: simplifying screening for primary liver cancer - do the LCR1 and LCR2 tests hold the key? Authors' reply.

Poynard T, Deckmyn O, Housset C; HECAM-FibroFrance Group.

Aliment Pharmacol Ther. 2019 Mar;49(5):613-614. doi: 10.1111/apt.15135. No abstract available.

PMID:
30746767
6.

Editorial: Genetics of cholangiopathies.

Barbu V, Housset C.

Curr Opin Gastroenterol. 2019 Mar;35(2):63-64. doi: 10.1097/MOG.0000000000000510. No abstract available.

PMID:
30624246
7.

Modifier genes in cystic fibrosis-related liver disease.

Debray D, Corvol H, Housset C.

Curr Opin Gastroenterol. 2019 Mar;35(2):88-92. doi: 10.1097/MOG.0000000000000508.

8.

LCR1 and LCR2, two multi-analyte blood tests to assess liver cancer risk in patients without or with cirrhosis.

Poynard T, Peta V, Deckmyn O, Munteanu M, Moussalli J, Ngo Y, Rudler M, Lebray P, Pais R, Bonyhay L, Charlotte F, Thibault V, Fartoux L, Lucidarme O, Eyraud D, Scatton O, Savier E, Valantin MA, Ngo A, Drane F, Rosmorduc O, Imbert-Bismut F, Housset C, Thabut D, Ratziu V; HECAM-FibroFrance Group.

Aliment Pharmacol Ther. 2019 Feb;49(3):308-320. doi: 10.1111/apt.15082. Epub 2018 Dec 19.

9.

Diet-Induced Dysbiosis and Genetic Background Synergize With Cystic Fibrosis Transmembrane Conductance Regulator Deficiency to Promote Cholangiopathy in Mice.

Debray D, El Mourabit H, Merabtene F, Brot L, Ulveling D, Chrétien Y, Rainteau D, Moszer I, Wendum D, Sokol H, Housset C.

Hepatol Commun. 2018 Oct 10;2(12):1533-1549. doi: 10.1002/hep4.1266. eCollection 2018 Dec.

10.

Hepatic encephalopathy: Another brick in the wall.

Weiss N, Housset C, Thabut D.

J Hepatol. 2019 Jan;70(1):8-10. doi: 10.1016/j.jhep.2018.10.016. Epub 2018 Nov 7. No abstract available.

PMID:
30414737
11.

Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease.

Munteanu M, Pais R, Peta V, Deckmyn O, Moussalli J, Ngo Y, Rudler M, Lebray P, Charlotte F, Thibault V, Lucidarme O, Ngo A, Imbert-Bismut F, Housset C, Thabut D, Ratziu V, Poynard T; FibroFrance Group.

Aliment Pharmacol Ther. 2018 Nov;48(10):1117-1127. doi: 10.1111/apt.14990. Epub 2018 Oct 17.

12.

Endoplasmic reticulum stress induces inverse regulations of major functions in portal myofibroblasts during liver fibrosis progression.

Loeuillard E, El Mourabit H, Lei L, Lemoinne S, Housset C, Cadoret A.

Biochim Biophys Acta Mol Basis Dis. 2018 Dec;1864(12):3688-3696. doi: 10.1016/j.bbadis.2018.10.008. Epub 2018 Oct 4.

PMID:
30292633
13.

Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French-Spanish experience.

Lemoinne S, Pares A, Reig A, Ben Belkacem K, Kemgang Fankem AD, Gaouar F, Poupon R, Housset C, Corpechot C, Chazouillères O.

Clin Res Hepatol Gastroenterol. 2018 Dec;42(6):521-528. doi: 10.1016/j.clinre.2018.06.009. Epub 2018 Aug 9.

14.

The IGF2/IR/IGF1R Pathway in Tumor Cells and Myofibroblasts Mediates Resistance to EGFR Inhibition in Cholangiocarcinoma.

Vaquero J, Lobe C, Tahraoui S, Clapéron A, Mergey M, Merabtene F, Wendum D, Coulouarn C, Housset C, Desbois-Mouthon C, Praz F, Fouassier L.

Clin Cancer Res. 2018 Sep 1;24(17):4282-4296. doi: 10.1158/1078-0432.CCR-17-3725. Epub 2018 May 1.

15.

Gallstone disease, towards a better understanding and clinical practice.

Housset C.

Curr Opin Gastroenterol. 2018 Mar;34(2):57-58. doi: 10.1097/MOG.0000000000000425. No abstract available.

PMID:
29266010
16.

Cystic Fibrosis-related Liver Disease: Research Challenges and Future Perspectives.

Debray D, Narkewicz MR, Bodewes FAJA, Colombo C, Housset C, de Jonge HR, Jonker JW, Kelly DA, Ling SC, Poynard T, Sogni P, Trauner M, Witters P, Baumann U, Wilschanski M, Verkade HJ.

J Pediatr Gastroenterol Nutr. 2017 Oct;65(4):443-448. doi: 10.1097/MPG.0000000000001676.

PMID:
28753176
17.

Comparison of in silico prediction and experimental assessment of ABCB4 variants identified in patients with biliary diseases.

Khabou B, Durand-Schneider AM, Delaunay JL, Aït-Slimane T, Barbu V, Fakhfakh F, Housset C, Maurice M.

Int J Biochem Cell Biol. 2017 Aug;89:101-109. doi: 10.1016/j.biocel.2017.05.028. Epub 2017 Jun 3.

PMID:
28587926
18.

Expression patterns of nuclear receptors in parenchymal and non-parenchymal mouse liver cells and their modulation in cholestasis.

Gonzalez-Sanchez E, Firrincieli D, Housset C, Chignard N.

Biochim Biophys Acta Mol Basis Dis. 2017 Jul;1863(7):1699-1708. doi: 10.1016/j.bbadis.2017.04.004. Epub 2017 Apr 6.

19.

Targeted pharmacotherapies for defective ABC transporters.

Vauthier V, Housset C, Falguières T.

Biochem Pharmacol. 2017 Jul 15;136:1-11. doi: 10.1016/j.bcp.2017.02.020. Epub 2017 Feb 27. Review.

PMID:
28245962
20.

Updates on primary sclerosing cholangitis.

Housset C.

Curr Opin Gastroenterol. 2017 Mar;33(2):69-70. doi: 10.1097/MOG.0000000000000342. No abstract available.

PMID:
28079751
21.

Functional defect of variants in the adenosine triphosphate-binding sites of ABCB4 and their rescue by the cystic fibrosis transmembrane conductance regulator potentiator, ivacaftor (VX-770).

Delaunay JL, Bruneau A, Hoffmann B, Durand-Schneider AM, Barbu V, Jacquemin E, Maurice M, Housset C, Callebaut I, Aït-Slimane T.

Hepatology. 2017 Feb;65(2):560-570. doi: 10.1002/hep.28929. Epub 2016 Dec 24.

PMID:
28012258
22.

Functions of the Gallbladder.

Housset C, Chrétien Y, Debray D, Chignard N.

Compr Physiol. 2016 Jun 13;6(3):1549-77. doi: 10.1002/cphy.c150050. Review.

PMID:
27347902
23.

Portal myofibroblasts connect angiogenesis and fibrosis in liver.

Lemoinne S, Thabut D, Housset C.

Cell Tissue Res. 2016 Sep;365(3):583-9. doi: 10.1007/s00441-016-2443-5. Epub 2016 Jun 21. Review.

PMID:
27324023
24.

Fatty liver is an independent predictor of early carotid atherosclerosis.

Pais R, Giral P, Khan JF, Rosenbaum D, Housset C, Poynard T, Ratziu V; LIDO Study Group.

J Hepatol. 2016 Jul;65(1):95-102. doi: 10.1016/j.jhep.2016.02.023. Epub 2016 Apr 26.

PMID:
27129836
25.

Culture Model of Rat Portal Myofibroblasts.

El Mourabit H, Loeuillard E, Lemoinne S, Cadoret A, Housset C.

Front Physiol. 2016 Mar 31;7:120. doi: 10.3389/fphys.2016.00120. eCollection 2016.

26.

Development of an in vitro model to test antifibrotic drugs on primary human liver myofibroblasts.

Aoudjehane L, Boelle PY, Bisch G, Delelo R, Paye F, Scatton O, Housset C, Becquart J, Calmus Y, Conti F.

Lab Invest. 2016 Jun;96(6):672-9. doi: 10.1038/labinvest.2016.36. Epub 2016 Mar 7.

27.

A PDZ-Like Motif in the Biliary Transporter ABCB4 Interacts with the Scaffold Protein EBP50 and Regulates ABCB4 Cell Surface Expression.

Venot Q, Delaunay JL, Fouassier L, Delautier D, Falguières T, Housset C, Maurice M, Aït-Slimane T.

PLoS One. 2016 Jan 20;11(1):e0146962. doi: 10.1371/journal.pone.0146962. eCollection 2016.

28.

Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity.

Poynard T, Deckmyn O, Munteanu M, Ngo Y, Drane F, Castille JM, Housset C, Ratziu V; FIBROFRANCE Group.

BMJ Open. 2015 Dec 23;5(12):e010017. doi: 10.1136/bmjopen-2015-010017.

29.

A functional classification of ABCB4 variations causing progressive familial intrahepatic cholestasis type 3.

Delaunay JL, Durand-Schneider AM, Dossier C, Falguières T, Gautherot J, Davit-Spraul A, Aït-Slimane T, Housset C, Jacquemin E, Maurice M.

Hepatology. 2016 May;63(5):1620-31. doi: 10.1002/hep.28300. Epub 2015 Dec 23.

PMID:
26474921
30.

Infection of Human Liver Myofibroblasts by Hepatitis C Virus: A Direct Mechanism of Liver Fibrosis in Hepatitis C.

Aoudjehane L, Bisch G, Scatton O, Granier C, Gaston J, Housset C, Roingeard P, Cosset FL, Perdigao F, Balladur P, Wakita T, Calmus Y, Conti F.

PLoS One. 2015 Jul 27;10(7):e0134141. doi: 10.1371/journal.pone.0134141. eCollection 2015.

31.

Mitogen-activated protein kinase-activated protein kinase 2 mediates resistance to hydrogen peroxide-induced oxidative stress in human hepatobiliary cancer cells.

Nguyen Ho-Bouldoires TH, Clapéron A, Mergey M, Wendum D, Desbois-Mouthon C, Tahraoui S, Fartoux L, Chettouh H, Merabtene F, Scatton O, Gaestel M, Praz F, Housset C, Fouassier L.

Free Radic Biol Med. 2015 Dec;89:34-46. doi: 10.1016/j.freeradbiomed.2015.07.011. Epub 2015 Jul 11.

PMID:
26169728
32.

Nuclear receptors in acute and chronic cholestasis.

Gonzalez-Sanchez E, Firrincieli D, Housset C, Chignard N.

Dig Dis. 2015;33(3):357-66. doi: 10.1159/000371688. Epub 2015 May 27. Review.

PMID:
26045270
33.

Mechanical induction of the tumorigenic β-catenin pathway by tumour growth pressure.

Fernández-Sánchez ME, Barbier S, Whitehead J, Béalle G, Michel A, Latorre-Ossa H, Rey C, Fouassier L, Claperon A, Brullé L, Girard E, Servant N, Rio-Frio T, Marie H, Lesieur S, Housset C, Gennisson JL, Tanter M, Ménager C, Fre S, Robine S, Farge E.

Nature. 2015 Jul 2;523(7558):92-5. doi: 10.1038/nature14329. Epub 2015 May 11.

PMID:
25970250
34.

Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease.

Fedchuk L, Nascimbeni F, Pais R, Charlotte F, Housset C, Ratziu V; LIDO Study Group.

Aliment Pharmacol Ther. 2014 Nov;40(10):1209-22. doi: 10.1111/apt.12963. Epub 2014 Sep 29.

35.

Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia.

Perazzo H, Munteanu M, Ngo Y, Lebray P, Seurat N, Rutka F, Couteau M, Jacqueminet S, Giral P, Monneret D, Imbert-Bismut F, Ratziu V, Hartemann-Huertier A, Housset C, Poynard T; FLIP Consortium.

Aliment Pharmacol Ther. 2014 Nov;40(9):1081-93. doi: 10.1111/apt.12946. Epub 2014 Sep 3.

36.

Portal myofibroblasts promote vascular remodeling underlying cirrhosis formation through the release of microparticles.

Lemoinne S, Cadoret A, Rautou PE, El Mourabit H, Ratziu V, Corpechot C, Rey C, Bosselut N, Barbu V, Wendum D, Feldmann G, Boulanger C, Henegar C, Housset C, Thabut D.

Hepatology. 2015 Mar;61(3):1041-55. doi: 10.1002/hep.27318. Epub 2015 Jan 22.

PMID:
25043701
37.

ABCB4: Insights from pathobiology into therapy.

Falguières T, Aït-Slimane T, Housset C, Maurice M.

Clin Res Hepatol Gastroenterol. 2014 Oct;38(5):557-63. doi: 10.1016/j.clinre.2014.03.001. Epub 2014 Jun 19. Review.

PMID:
24953525
38.

Improved prognosis of septic shock in patients with cirrhosis: a multicenter study*.

Galbois A, Aegerter P, Martel-Samb P, Housset C, Thabut D, Offenstadt G, Ait-Oufella H, Maury E, Guidet B; Collège des Utilisateurs des Bases des données en Réanimation (CUB-Réa) Group.

Crit Care Med. 2014 Jul;42(7):1666-75. doi: 10.1097/CCM.0000000000000321.

PMID:
24732239
39.

Phosphorylation of ABCB4 impacts its function: insights from disease-causing mutations.

Gautherot J, Delautier D, Maubert MA, Aït-Slimane T, Bolbach G, Delaunay JL, Durand-Schneider AM, Firrincieli D, Barbu V, Chignard N, Housset C, Maurice M, Falguières T.

Hepatology. 2014 Aug;60(2):610-21. doi: 10.1002/hep.27170. Epub 2014 May 19.

PMID:
24723470
40.

EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition.

Clapéron A, Mergey M, Nguyen Ho-Bouldoires TH, Vignjevic D, Wendum D, Chrétien Y, Merabtene F, Frazao A, Paradis V, Housset C, Guedj N, Fouassier L.

J Hepatol. 2014 Aug;61(2):325-32. doi: 10.1016/j.jhep.2014.03.033. Epub 2014 Apr 3.

PMID:
24704591
41.

Characterization of animal models for primary sclerosing cholangitis (PSC).

Fickert P, Pollheimer MJ, Beuers U, Lackner C, Hirschfield G, Housset C, Keitel V, Schramm C, Marschall HU, Karlsen TH, Melum E, Kaser A, Eksteen B, Strazzabosco M, Manns M, Trauner M; International PSC Study Group (IPSCSG).

J Hepatol. 2014 Jun;60(6):1290-303. doi: 10.1016/j.jhep.2014.02.006. Epub 2014 Feb 19. Review.

42.

The emerging roles of microvesicles in liver diseases.

Lemoinne S, Thabut D, Housset C, Moreau R, Valla D, Boulanger CM, Rautou PE.

Nat Rev Gastroenterol Hepatol. 2014 Jun;11(6):350-61. doi: 10.1038/nrgastro.2014.7. Epub 2014 Feb 4. Review.

PMID:
24492276
43.

Illuminating liver fibrosis with vitamin D.

Firrincieli D, Braescu T, Housset C, Chignard N.

Clin Res Hepatol Gastroenterol. 2014 Feb;38(1):5-8. doi: 10.1016/j.clinre.2013.10.004. Epub 2013 Nov 12.

PMID:
24238723
44.

Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor.

Clapéron A, Mergey M, Aoudjehane L, Ho-Bouldoires TH, Wendum D, Prignon A, Merabtene F, Firrincieli D, Desbois-Mouthon C, Scatton O, Conti F, Housset C, Fouassier L.

Hepatology. 2013 Dec;58(6):2001-11. doi: 10.1002/hep.26585. Epub 2013 Oct 25. Erratum in: Hepatology. 2014 Aug;60(2):770.

PMID:
23787814
45.

Vitamin D nuclear receptor deficiency promotes cholestatic liver injury by disruption of biliary epithelial cell junctions in mice.

Firrincieli D, Zúñiga S, Rey C, Wendum D, Lasnier E, Rainteau D, Braescu T, Falguières T, Boissan M, Cadoret A, Housset C, Chignard N.

Hepatology. 2013 Oct;58(4):1401-12. doi: 10.1002/hep.26453. Epub 2013 Sep 6.

46.

Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors.

Chettouh H, Fartoux L, Aoudjehane L, Wendum D, Clapéron A, Chrétien Y, Rey C, Scatton O, Soubrane O, Conti F, Praz F, Housset C, Rosmorduc O, Desbois-Mouthon C.

Cancer Res. 2013 Jul 1;73(13):3974-86. doi: 10.1158/0008-5472.CAN-12-3824. Epub 2013 Apr 30.

47.

Genotype-phenotype relationships in the low-phospholipid-associated cholelithiasis syndrome: a study of 156 consecutive patients.

Poupon R, Rosmorduc O, Boëlle PY, Chrétien Y, Corpechot C, Chazouillères O, Housset C, Barbu V.

Hepatology. 2013 Sep;58(3):1105-10. doi: 10.1002/hep.26424. Epub 2013 Jul 29.

PMID:
23533021
48.

Immunohistochemical profile of ezrin and radixin in human liver epithelia during fetal development and pediatric cholestatic diseases.

Clapéron A, Debray D, Redon MJ, Mergey M, Ho-Bouldoires TH, Housset C, Fabre M, Fouassier L.

Clin Res Hepatol Gastroenterol. 2013 Apr;37(2):142-51. doi: 10.1016/j.clinre.2013.02.001. Epub 2013 Mar 16.

PMID:
23507543
49.

Origins and functions of liver myofibroblasts.

Lemoinne S, Cadoret A, El Mourabit H, Thabut D, Housset C.

Biochim Biophys Acta. 2013 Jul;1832(7):948-54. doi: 10.1016/j.bbadis.2013.02.019. Epub 2013 Mar 5.

50.

Including osteoprotegerin and collagen IV in a score-based blood test for liver fibrosis increases diagnostic accuracy.

Bosselut N, Taibi L, Guéchot J, Zarski JP, Sturm N, Gelineau MC, Poggi B, Thoret S, Lasnier E, Baudin B, Housset C, Vaubourdolle M; ANRS HCEP 23 Fibrostar Group.

Clin Chim Acta. 2013 Jan 16;415:63-8. doi: 10.1016/j.cca.2012.09.020. Epub 2012 Sep 27.

PMID:
23022619

Supplemental Content

Loading ...
Support Center